Date posted
May
21
Michigan Congressman John Moolenaar, Chair of the House Select Committee on the Chinese Communist Party, has introduced the Securing Innovation...
Read PostFederal Advocacy
Voices Heard in Washington: Federal Advocacy for Bio Community
Stay updated on federal initiatives and policies influencing the bio-industry across the country. This category highlights national-level advocacy efforts, initiatives, and developments driving innovation and growth across the industry.
Advocacy
Advocacy :
Federal Advocacy
Advocacy :
State Advocacy
Association Updates
BioConnections® Jobs
Event
Event :
Industry Event
Event :
MichBio Advocacy Events
Event :
MichBio Networking Event
Event :
MichBio Signature Event
Event :
MichBio Webinar
Event :
Partner Event
Member Feature
News
News :
Industry News
News :
Member News
News :
MichBio News/Statement
News :
Michigan News
Date posted
May
21
The House Energy & Commerce Committee’s Health Subcommittee has advanced bipartisan legislation aimed at accelerating the FDA’s...
Read Post
Date posted
May
4
For decades, drug development has followed a predictable cadence: run a trial, wait, analyze, submit. Progress has often been defined as much by...
Read Post
Date posted
May
4
Momentum in Congress around Medicare coverage reform for medical devices appears to have slowed following the Administration’s introduction...
Read Post
Date posted
Apr
19
MichBio joined leaders from across the country in Washington, D.C. for the 2026 Council of StateBioscience Associations (CSBA) Fly-In, bringing...
Read Post
Date posted
Apr
6
Congress passed long-awaited legislation to reauthorize the SBIR and STTR programs, sending the bill to President Trump on April 1, 2026, for...
Read Post
Date posted
Apr
6
The White House this past week announced a sweeping new tariff policy targeting imported patented pharmaceutical products, positioning the move as...
Read Post
Date posted
Apr
6
The Trump Administration’s FY2027 budget proposal underscores a significant shift in federal priorities—pairing a record $1.5 trillion...
Read Post
Date posted
Mar
20
The U.S. drug development landscape is entering a pivotal transition, as federal regulators and research funders accelerate efforts to reduce...
Read Post
Date posted
Mar
20
A new proposal from the U.S. Environmental Protection Agency (EPA) is reshaping the regulatory landscape for medical device sterilization -...
Read Post
Date posted
Mar
20
The FDA’s recent draft guidance clarifying the scope of 3-year New Clinical Investigation (NCI) exclusivity is more than a technical update...
Read Post
Date posted
Mar
20
A bipartisan group of lawmakers has introduced new legislation aimed at tackling a foundational challenge in AI-driven drug discovery - the lack...
Read Post